A ging is an important risk factor for developing cardiovascular disease, and also the least understood. 1, 2 Venous thromboembolism (VTE) is characterized by the development of thrombi in the deep veins of the legs; these thrombi are prone to dislodging and embolizing to the lungs. This condition accounts for 140 000 to 200 000 deaths each year in the United States. 3, 4 The risk of developing VTE substantially increases with age, and individuals over the age of 55 years have an annual incidence 5 to 7 times higher than young adults. 5 Although VTE in the younger population is often explained by mutations in hemostatic genes, mechanisms behind the increased risk of VTE in the elderly are less well understood.
Senescence is one cellular phenomenon known to be associated with aging. Cellular senescence is a stress-induced process that is controlled by cell cycle inhibitors and that promotes an irreversible growth arrest. 6 -9 p16 INK4a , a cell cycle inhibitor that promotes senescence, binds to cyclindependent kinases 4 and 6 to disrupt phosphorylation of the retinoblastoma protein, causing a G 1 cell cycle arrest. 10 Expression of p16 INK4a increases with age in many tissues and is a biomarker of aging. [11] [12] [13] [14] Furthermore, p16 INK4a expression correlates with biomarkers of senescence, such as senescence-associated ␤-galactosidase expression, and expression is associated with gerontogenic activities, such as smoking, physical inactivity, and ad libitum feeding in humans or mice. 11, 14 In some tissues such as pancreatic ␤-cells, neural stem cells, and hematopoietic stem or progenitor cells, the age-induced increase in p16 INK4a expression is associated with reduced cellular proliferation coupled with an impaired tissue response to injury. [15] [16] [17] Additionally, senescent cells are thought to contribute to aging pathology through the production of cytokines (interleukin-6) that further promote inflammation and cellular dysfunction. 18 The contribution of senescence to disease in the venous circulation and how it may be involved in age-related VTE or a possible prothrombotic phenotype remain largely uncharacterized. The aim of this study was to ascertain whether overexpression of p16 INK4a modified venous thrombus formation in several well-defined animal models. Our results demonstrate that p16 INK4a overexpression augments vascular occlusion and delayed thrombus resolution relative to wildtype controls. Furthermore, p16 INK4a transgenic mice display enhanced thrombin generation, increased thrombinantithrombin, and increased plasminogen activator inhibitor-1 (PAI-1) levels when exposed to low-dose lipopolysaccharide (LPS). Additionally, bone marrow transplantation between wild-type and p16 INK4a transgenic mice demonstrated a substantial contribution of hematopoietic cells to this phenotype. Overall, these results show that expression of p16 INK4a is involved in promoting a prothrombotic environment in the venous vasculature.
Methods
A detailed description of the methods is presented in the Supplemental Materials, available online at http://atvb.ahajournals.org.
Mice
All animal procedures were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee of University of North Carolina-Chapel Hill. The bacterial artificial chromosome transgenic mice overexpressing p16 INK4a used in this study have been described previously. 15
Hemostasis Model
Hemostasis was assessed as previously described. 19 Briefly, wildtype and p16 INK4a transgenic mice at 8 weeks of age were anesthetized with 2.5% tribromoethanol (T48402, Sigma-Aldrich, St. Louis, MO) at 0.1 mL/g body weight. The saphenous vein of anesthetized mice was exposed and transected with a 23-gauge needle. Once bleeding stopped, a longitudinal cut was made in the vessel, and the blood was gently wiped away with Kimwipes (Kimberly-Clark, Roswell, GA) until it clotted. The blood clot was disrupted using a 30-gauge needle, and the blood was gently wiped away. Clot disruption was repeated every time hemostasis occurred, and each hemostatic event was recorded using Chart software for 20 minutes.
FeCl 3 Vascular Injury
The saphenous vein thrombosis model was performed as previously described. 19 Briefly, the saphenous veins of anesthetized mice were exposed and dissected away from the saphenous artery. A 0.5ϫ2-mm piece of filter paper was soaked in 2.5% (nϭ4), 5% (nϭ5), or 10% (nϭ4) FeCl 3 (F7134, Sigma-Aldrich) and laid over the saphenous vein for 3 minutes. The filter paper was then removed, and the tissue was washed 3 times with warm saline. Blood flow was monitored using a 20-MHz Doppler flow probe (Indus Instruments, Webster, TX). Occlusion was defined as the absence of blood flow for 1 minute. The time to flow restriction was defined as the time after injury at first cessation of blood flow.
Rose Bengal Photochemical Vascular Injury
Photochemical injury was performed as previously described. 20 Briefly, both right and left saphenous veins of anesthetized mice were exposed. The left saphenous vein was catheterized using catheters made in-house using pulled PE-10 tubing (Braintree Scientific, Braintree, MA). Rose Bengal (R-3877, Sigma-Aldrich), diluted to 30 mg/mL in normal saline, was infused through the catheter at a dose of 75 mg/kg through a gastight syringe (Hamilton Co, Reno, NV). Before infusion of Rose Bengal, a 1.75-mW green light (540 nm) (Prizmatix, Southfield, MI) was directed 0.5 cm over the injury site on the right saphenous vein. Light was applied to the vessel until a stable thrombus (defined as the absence of blood flow for 1 minute) was achieved.
Thrombus Resolution
We developed a new method to measure thrombus resolution using the saphenous vein. Wild-type and p16 INK4a transgenic mice (nϭ3 per genotype at each time point) were subjected to 10% FeCl 3 injury to the saphenous vein. The tissue was then washed 3 times with warm saline, a single ligature was placed upstream of the thrombus using a 8-0 monofilament polypropylene suture to prevent embolization, and the leg was sutured closed. Mice were euthanized at various time points, and the saphenous neurovascular bundle was removed and fixed overnight in 4% paraformaldehyde and paraffin embedded. Five-micrometer sections were cut and hematoxylin and eosin (H&E) stained to visualize the presence of a thrombus under light microscopy. Vessels were sectioned through, and those sections showing the greatest area of occlusion were chosen for analysis. Such sections typically occurred near the center of the injured vessel. Images were analyzed using ImageJ software to calculate the percentage of the vessel lumen that remained occluded by a thrombus.
Low-Dose LPS Treatment
Wild-type and p16 INK4a transgenic mice were treated with 2 mg/kg intraperitoneal injection of LPS (L3012, Sigma-Aldrich). At various times (1, 3, and 5 hours), the mice (nϭ5 per genotype each time point) were anesthetized, and 1 mL of blood was collected from the inferior vena cava into 3.8% sodium citrate at a ratio of 1:9 using a 25-gauge needle. Whole blood was spun at 4000g for 15 minutes, and the platelet-poor plasma was collected and stored at Ϫ80°C until it was analyzed.
Bone Marrow Transplantation
This procedure was performed as described previously. 21 Briefly, mice were irradiated using a cesium-137 irradiator (JL Shepherd, San Fernando, CA) with a total of 11 Gy (2 doses of 550 rad, with a 4-hour rest) to abolish endogenous hematopoietic cells. Bone marrow cells were isolated from donor mice, 21 and 1ϫ10 7 cells were injected (100 L) into the retroorbital sinus. Four weeks after irradiation, recipient mice underwent FeCl 3 injury to the saphenous vein to determine vascular occlusion times. At termination, recipient mouse bone marrow was genotyped to verify successful repopulation of donor cells by polymerase chain reaction. Expression of p16 INK4a was compared with an interleukin-2 loading control.
Statistics
All statistical analyses were performed with GraphPad Prism. All measurements are represented as the meanϮSEM. One-way ANOVA or Student t test was performed where indicated. Values of PϽ0.05 were considered statistically significant.
Results p16 INK4a Transgenic and Wild-Type Mice Respond Similarly in a Hemostasis Model
To determine the contribution of p16 INK4a overexpression to potential hemostatic defects, mice initially underwent a model of saphenous vein hemostasis. No difference was observed in the number of hemostatic clots formed over 20 minutes between transgenic mice (25.8Ϯ3.4) and wild-type mice (25.8Ϯ2.1, Figure 1A ) or in the average time to hemostasis (33.5Ϯ3.7 and 36.6Ϯ2.6 seconds, respectively, Figure 1B ). Furthermore, no significant differences were observed in body weight, venous blood flow velocity, plasma prothrombin time, and complete blood count between the 2 groups of mice ( Supplemental Table I ). These results suggest that there is no obvious physical or hematologic phenotype in the p16 INK4a transgenic mice at the ages studied.
p16 INK4a Transgenic Mice Display a Prothrombotic Phenotype in an FeCl 3 Injury Model
FeCl 3 injury is a well-established mechanism for inducing thrombus formation in vivo. [22] [23] [24] We first demonstrated a dose-dependent effect of FeCl 3 on the occlusion time in the saphenous vein, exposing wild-type mice to 2.5%, 5%, and 10% FeCl 3 injuries to the saphenous vein ( Figure 2A ).
Wild-type and p16 INK4a transgenic mice were then subjected to FeCl 3 (5%) injury to the saphenous vein. The p16 INK4a transgenic mice showed a significantly shorter time to occlusion (13.1Ϯ0.4 minutes) compared with wild-type mice (19.7Ϯ1.1 minute, Figure 2B ). Furthermore, the time to flow restriction was also measured. The p16 INK4a transgenic mice demonstrated shorter times to flow restriction (6.4Ϯ0.91) compared with wild-type controls (8.7Ϯ0.54, PϽ0.05, data not shown). These results indicate that overexpression of p16 INK4a results in a prothrombotic phenotype following vascular injury.
p16 INK4a Transgenic Mice Display a Prothrombotic Phenotype in a Photochemical Injury Model
The excitation of Rose Bengal to induce photochemical injury is another well-established mechanism for inducing thrombus formation in vivo. [25] [26] [27] On photochemical injury to the saphenous vein, p16 INK4a transgenic mice displayed a significantly shorter time to occlusion (12.7Ϯ2.0 minutes) compared with wild-type mice (18.6Ϯ1.9 minutes, Figure 3 ). These results suggest that the prothrombotic phenotype in mice overexpressing p16 INK4a can be recapitulated in other vascular injury models.
p16 INK4a Transgenic Mice Exhibit Delayed Thrombus Resolution
Venous thrombosis is characterized by the presence of unresolved thrombi in the lower extremities. To study the effect of Figure 4A ). Representative images show little difference in percentage of occlusion at 1 day ( Figure 4B ) between p16 INK4a transgenic and wild-type mice. Black staining represents FeCl 3 trapped within the thrombus. At 10 days, we observed that residual FeCl 3 was mostly contained within inflammatory macrophages and was present in the perivascular space of wild-type mice. However, residual FeCl 3 contained within macrophages was still present in the intravascular space of p16 INK4a transgenic mice at 10 days ( Figure 4B ). These results demonstrate a defect in thrombus resolution with p16 INK4a overexpression.
p16 INK4a Transgenic Mice Display Enhanced Thrombin Generation in Response to LPS Challenge
Chronic inflammation and endothelial dysfunction have been linked to enhanced thrombin generation and the risk of venous thrombosis. 28 -30 LPS is known to activate the vascular endothe-lium and promote the formation of spontaneous thrombi. [31] [32] [33] [34] To study the effects of inflammation-induced coagulation, we exposed p16 INK4a transgenic and wild-type mice to low-dose LPS. When analyzed by calibrated automated thrombography, plasma from the p16 INK4a transgenic mice showed a significantly shorter lag time to initiation of thrombin generation and time to peak amount of thrombin generated at all time points post-LPS treatment (Table) . The peak amount of thrombin generated was significantly higher in p16 INK4a transgenic mice 3 and 5 hours after LPS treatment (Table) . The observed differences in thrombin generation demonstrates p16 INK4a transgenic mice are able to generate more thrombin and have a prothrombotic phenotype when challenged with LPS.
p16 INK4a Expression in Hematopoietic Cells Contributes to the Observed Prothrombotic Phenotype
To determine the relative contribution of p16 INK4a expression in the hematopoietic cell compartment to the observed prothrombotic phenotype, bone marrow transplants were performed between transgenic and wild-type mice. Following transplantation and recovery, mice were subjected to 10% FeCl 3 injury to the saphenous vein. Consistent with our previous results ( Figure 2B wild-type mice receiving wild-type bone marrow (13.0Ϯ0.79 minutes, Figure 5 ). Interestingly, transgenic mice receiving wild-type bone marrow displayed occlusion times similar to those of wild-type mice (12.8Ϯ1.3 minutes), whereas wildtype mice receiving transgenic bone marrow displayed occlusion times similar to those of transgenic mice (9.5Ϯ0.61 minutes, Figure 5 ). Polymerase chain reaction results confirmed successful reconstitution by donor bone marrow cells (Supplemental Figure III) . These results demonstrate that the effects of p16 INK4a overexpression are, at least in part, mediated by hematopoietic cells.
Discussion
Senescence is a complex process that is thought to contribute to cardiovascular pathologies associated with aging. Despite several reviews describing prothrombotic changes in senescent vascular endothelial cells, 35, 36 no studies have described a venous thrombotic phenotype in mice overexpressing senescence-promoting genes. In the current study, we examined parameters that define venous thrombotic potential in a mouse model of premature senescence through transgenic overexpression of the cell cycle inhibitor p16 INK4a We have demonstrated a prothrombotic phenotype using 2 different vascular injury models. Exposure of the vessel to FeCl 3 is a type of biochemical injury that results in endothelial denudation and exposure of the subendothelium following lipid peroxidation. 37 This type of oxidative damage produces thrombi that are rich in platelets but also contain red blood cells both encased in a dense fibrin meshwork, indicating a role for soluble plasma factors driving thrombus formation. 38 -40 Rose Bengal is a fluorescein-based chemical that is excited to produce reactive oxygen species when exposed to green light at 540 nm. This results in endothelial activation, although there is very little denudation, and is accompanied by rapid platelet adhesion. Thrombi in this model are composed primarily of platelets and contain less fibrin, implying that this process is mostly platelet driven. 38 The observation that p16 INK4a transgenic mice exhibit shorter occlusion times in both of these models suggests that there is likely a contribution by both soluble plasma factors and circulating cells. The differences observed in the time to flow restriction may reflect altered rates of thrombus growth between wild-type and p16 INK4a transgenic mice, which could be indicative of the potential to produce larger thrombi.
In addition to more rapid rates of venous occlusion, p16 INK4a transgenic mice also display impaired thrombus resolution. The percentage of occlusion appears to be correlated with the sustaining of inflammatory infiltration. It is possible that the inability to clear residual FeCl 3 from the intravascular space could be involved in further promoting thrombus formation. The increased production of PAI-1 observed in p16 INK4a transgenic mice could also partly explain the thrombus resolution defect (Supplemental Figure  II) . Evidence in the literature suggests increased circulating PAI-1 could have a negative impact on wound healing and fibrinolysis. Originally, Farrehi et al demonstrated enhanced fibrinolysis in PAI-1-deficient mice. 41 Eitzman et al found that transgenic mice overexpressing PAI-1 have more severe fibrosis following bleomycin-induced lung injury. 42 Zaman et al showed a profibrotic effect of PAI-1 overexpression in the heart following myocardial infarction. 43 Recently, McDonald et al demonstrated that aged mice display impaired thrombus resolution following stasis induced by inferior vena cava ligation. 44 In addition, they reported differences in various plasma and venous endothelium-associated proteins between aged and young wild-type mice. 44 Although an exact mechanism to account for the observed thrombus resolution defect in the aged mice is not yet known, 44 it is possible that changes in both the vessel wall and soluble plasma factors contribute, which may also be true of p16 INK4a overexpressing mice.
To better understand differences in thrombus formation between p16 INK4a transgenic and wild-type mice, coagulation parameters in mouse plasma samples were analyzed by calibrated automated thrombography after inducing endothelial dysfunction with LPS. Plasma analysis by calibrated automated thrombography is sensitive to changes in coagulation factor levels 45 and able to detect differences in thrombin generation parameters following a thrombotic event in human patients. 46 Our results show that p16 INK4a transgenic mice are able to initiate thrombin generation faster, achieve a higher peak amount of thrombin, and peak at a faster rate than wild-type controls. Therefore, p16 INK4a transgenic mice exhibit greater thrombin generation after LPS challenge compared with wild-type controls. To complement these data, p16 INK4a transgenic mice also showed elevated plasma levels of thrombin-antithrombin and PAI-1 following LPS challenge. These markers are commonly used to measure activa- tion of coagulation (thrombin-antithrombin) 33, 47 and endothelial activation (PAI-1). 48, 49 Yamamoto et al showed that aged mice had elevated induction of PAI-1 compared with young mice after LPS treatment, suggesting that PAI-1 is important in endotoxin-induced thrombosis. 31 Because PAI-1 is both a marker of endothelial cell senescence and a potent fibrinolysis inhibitor, 50 it could also participate in the delayed thrombus resolution seen in p16 INK4a transgenic mice.
To begin establishing a mechanism for the observed differences between wild-type and p16 INK4a transgenic mice, bone marrow transplants were performed to determine the contribution of hematopoietic cells to the prothrombotic phenotype. We found that wild-type mice given p16 INK4a transgenic bone marrow had occlusion times very similar to those of transgenic controls. Similarly, p16 INK4a transgenic mice given wild-type bone marrow had occlusion times very similar to those of wild-type controls. These data show that the prothrombotic phenotype observed in mice overexpressing this gene is attributed to p16 INK4a expression in hematopoietic cells.
A growing body of in vitro evidence suggests that senescence in the vascular endothelium may also participate in the transition to a procoagulant state during aging. Senescence in the vascular endothelium is associated with an array of phenotypic changes with pathological consequences. 7, 8 These changes include upregulation of PAI-1, inflammatory cytokines (including interleukin-1␣ and interleukin-6), matrix metalloproteinases, and the downregulation of endothelial nitric oxide synthase. 35, 36, 51 Thus, a role for the endothelium cannot be discounted and may warrant further investigation in this model.
In contradistinction to the present data supporting a role for p16 INK4a in venous thrombosis, a differing role for the expression of p16 INK4a in arterial vascular diseases has been suggested. Through genome-wide association studies, several groups have found a link between single-nucleotide polymorphisms on chromosome 9p21.3 close to the p16 INK4a open-reading frame and several atherosclerotic diseases (coronary artery disease, ischemic stroke, abdominal aortic aneurysm). 52 Liu et al have recently shown that individuals harboring the single-nucleotide polymorphism genotypes associated with increased atherosclerotic risk exhibit decreased expression of p16 INK4a and other INK4/ARF transcripts. 53 Individuals at increased risk appear to differ in the expression and splicing of linear and circular forms of ANRIL, a long, noncoding RNA emanating from the INK4a/ARF locus thought to participate in INK4a/ARF expression. 54 This observation suggests that decreased production of p16 INK4a is associated with an increased risk of atherosclerosis, likely through limiting aberrant or excess proliferation of cellular components of atheromatous plaques. This suggests that expression of antiproliferative molecules at the INK4a/ARF locus protects individuals from atherosclerosis. 52, 55 In accord with this view, mice lacking p16 INK4a have been shown to be more prone to vessel occlusion in a carotid artery injury model. 56 Our current data, combined with prior work in the venous system, 35, 36 suggest the intriguing possibility that age-induced p16 INK4a expression and cellular senescence might play oppos-ing roles with regard to thrombosis and atherosclerosis in the venous and arterial systems, respectively.
Characterizing the link between age-related genetic changes and age-related cardiovascular diseases, such as venous thrombosis, is of paramount importance. Overexpression of proteins such as p16 INK4a , which promote senescence and vascular dysfunction, could be the key age-related genetic change explaining cardiovascular maladies. Together, our results demonstrate that p16 INK4a overexpression and cellular senescence contribute to a prothrombotic phenotype and defective thrombus resolution. The results of this study provide the foundation for research on the effects of vascular senescence on venous thrombosis.
